Showing results (461-470 of 686) with videos related to
Sort By:
Pageof 69
Cell & Bioscience|March 8, 2025
Transcriptomics, lipidomics, and single-nucleus RNA sequencing integration: exploring sphingolipids in MASH-HCC progressionJing Zeng, Grayson Way, Nan Wu, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2021
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim AnalysisZobair M Younossi, Maria Stepanova, Fatema Nader, et al.Journal of Hepatology|November 18, 2021
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE studyMary E Rinella, Jean-Francois Dufour, Quentin M Anstee, et al.Gastroenterology|September 18, 2018
Factors Associated With Histologic Response in Adult Patients With Nonalcoholic SteatohepatitisRohit Loomba, Arun J Sanyal, Kris V Kowdley, et al.Journal of the American College of Cardiology|February 4, 2026
MASLD, MASH, and the CKM Spectrum: A Roadmap for Multiorgan Clinical Trial DesignFaiez Zannad, Muhammad Shahzeb Khan, Nisha Bansal, et al.Science Translational Medicine|September 10, 2025
Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitisHongxue Shi, Xiaobo Wang, Christopher Sloas, et al.Hepatology (Baltimore, Md.)|November 1, 2020
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of SteatohepatitisBubu A Banini, Divya P Kumar, Sophie Cazanave, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 13, 2016
Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte systemA Dash, R A Figler, B R Blackman, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 9, 2004
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantationR Todd Stravitz, Mitchell L Shiffman, Arun J Sanyal, et al.The American Journal of Gastroenterology|April 1, 2006
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trialRobert J Fontana, Arun J Sanyal, Savant Mehta, et al.Pageof 69